Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Diplomat Pharmacy Inc (DPLO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,020,239
  • Shares Outstanding, K 74,475
  • Annual Sales, $ 4,485 M
  • Annual Income, $ 15,510 K
  • 36-Month Beta 0.98
  • Price/Sales 0.19
  • Price/Cash Flow 7.48
  • Price/Book 1.34

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/18
See More
  • Average Estimate 0.24
  • Number of Estimates 8
  • High Estimate 0.27
  • Low Estimate 0.22
  • Prior Year 0.18
  • Growth Rate Est. (year over year) +33.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
12.90 +6.24%
on 02/08/19
14.53 -5.71%
on 01/31/19
+0.21 (+1.56%)
since 01/18/19
3-Month
12.30 +11.38%
on 01/08/19
16.35 -16.21%
on 12/07/18
-1.28 (-8.54%)
since 11/19/18
52-Week
12.30 +11.38%
on 01/08/19
28.74 -52.33%
on 06/22/18
-10.40 (-43.15%)
since 02/16/18

Most Recent Stories

More News
Diplomat Pharmaceuticals (DPLO) Reports Next Week: Wall Street Expects Earnings Growth

Diplomat Pharmaceuticals (DPLO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

DPLO : 13.70 (-0.36%)
Diplomat to Present at Investor Conferences in February, March 2019

Diplomat Pharmacy, Inc. (NYSE: DPLO) executives will participate in four upcoming investor conferences.

DPLO : 13.70 (-0.36%)
SmarTrend Watching for Potential Rebound in Shares of Diplomat Pharmac After 2.17% Loss

Diplomat Pharmac (NYSE:DPLO) traded in a range yesterday that spanned from a low of $13.39 to a high of $13.55. Yesterday, the shares fell 2.2%, which took the trading range below the 3-day low of $13.45...

DPLO : 13.70 (-0.36%)
Diplomat to Release 2018 Financial Results, 2019 Guidance Feb. 25

Diplomat Pharmacy, Inc. (NYSE: DPLO), will report its fourth-quarter and year-end 2018 financial results -- and provide 2019 guidance -- after market close Monday, Feb. 25. A conference call and live webcast...

DPLO : 13.70 (-0.36%)
Diplomat Pharmac Shares Down 8.0% Since SmarTrend's Sell Call (DPLO)

SmarTrend identified a Downtrend for Diplomat Pharmac (NYSE:DPLO) on November 7th, 2018 at $14.37. In approximately 2 months, Diplomat Pharmac has returned 8.00% as of today's recent price of $13.22.

DPLO : 13.70 (-0.36%)
Recent Analysis Shows T-Mobile US, Thor Industries, Integra LifeSciences, Diplomat Pharmacy, Tile Shop Hldgs, and Compass Diversified Market Influences -- Renewed Outlook, Key Drivers of Growth

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of T-Mobile US, Inc. (NASDAQ:TMUS),...

TMUS : 72.52 (+0.65%)
TTS : 6.22 (-16.51%)
IART : 51.17 (+0.22%)
THO : 69.45 (+1.37%)
CODI : 15.68 (-0.95%)
DPLO : 13.70 (-0.36%)
Diplomat Provides Updated 2018 Guidance and Preliminary 2019 Outlook

Diplomat Pharmacy, Inc. (NYSE: DPLO), is updating its 2018 financial guidance and providing a preliminary 2019 outlook in connection with its presentation today at the JP Morgan Healthcare Conference in...

DPLO : 13.70 (-0.36%)
Diplomat Partners With CSI Specialty Group to Expand Health System Services

Diplomat Pharmacy, Inc. (NYSE: DPLO), and CSI Specialty Group, a globally recognized specialty pharmacy consulting firm, have launched a program for hospitals and health systems interested in starting...

DPLO : 13.70 (-0.36%)
Diplomat to Participate in 37th Annual J.P. Morgan Healthcare Conference

Diplomat Pharmacy, Inc. (NYSE: DPLO), executives will present at this year's J.P. Morgan Healthcare Conference in San Francisco.

JPM : 105.18 (-0.35%)
DPLO : 13.70 (-0.36%)
Diplomat Selects Inovalon's Specialty Pharmacy Platform

Inovalon (Nasdaq: INOV), a leading technology company providing advanced, cloud-based platforms empowering data-driven healthcare, today announced a multi-year deal with Diplomat (NYSE: DPLO), the nation's...

INOV : 14.94 (-0.40%)
DPLO : 13.70 (-0.36%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 32% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More Share

Trade DPLO with:

Business Summary

Diplomat Pharmacy, Inc. operates as an independent specialty pharmacy in the United States. It aids in the dispensing, delivery, dosing and reimbursement of clinically intensive and specialty drugs. The company focuses on medication management programs for people with complex chronic diseases, including...

See More

Key Turning Points

2nd Resistance Point 14.04
1st Resistance Point 13.87
Last Price 13.70
1st Support Level 13.53
2nd Support Level 13.36

See More

52-Week High 28.74
Fibonacci 61.8% 22.46
Fibonacci 50% 20.52
Fibonacci 38.2% 18.58
Last Price 13.70
52-Week Low 12.30

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar